Rhody Construction

NeuroSigma, Inc. is a leading medical device company based in La Canada Flintridge, CA, specializing in the development and commercialization of innovative treatments for neurological disorders. Their flagship product, the Monarch eTNS System, is the first FDA cleared device for treating pediatric Attention Deficit Hyperactivity Disorder (ADHD) as a monotherapy in patients aged 7 to 12 years old. Designed to be used in the comfort of the patient's home under the supervision of a caregiver during sleep, the device has shown promising results in improving symptoms of ADHD without the need for prescription medications. With a strong focus on patient safety and efficacy, NeuroSigma has gained recognition for its groundbreaking technology. The Monarch eTNS System has been associated with minimal side effects, such as drowsiness and an increase in appetite, while no serious adverse events have been reported. NeuroSigma continues to expand its reach globally, with recent approvals in Singapore and ongoing clinical trials. Committed to advancing the field of neurology, NeuroSigma aims to provide innovative solutions that improve the lives of individuals with neurological disorders.Generated from the website